Lymphangiogenesis: New mechanisms

Annals of the New York Academy of Sciences

Volumn 979, Issue , 2002, Pages 111-119

  Chang, Lynn ^a   Kaipainen, Arja ^a   Folkman, Judah ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Angiogenesis; Angiogenesis inhibitor; bFGF; Blood vessel endothelial cells; Lymphangiogenesis; Lymphangiogenesis inhibitor; Lymphatic endothelial cells; Murine cornea neovascularization; VEGF A; VEGF D

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR;

ANGIOGENESIS; ANIMAL MODEL; BLOOD VESSEL; CONFERENCE PAPER; CORNEA NEOVASCULARIZATION; DISEASE COURSE; INHIBITION KINETICS; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; MOLECULAR MECHANICS; MOUSE; NONHUMAN;

ANIMALIA; MURINAE;

EID: 0036964991     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04872.x     Document Type: Conference Paper

References (19)

1. FOLKMAN, J. 2000. Tumour angiogenesis. In Cancer Medicine, 5th ed. J.F. Holland et al., Eds. :32-152. B.C. Decker. Ontario, Canada.
2. FOLKMAN, J. 2001. Angiogenesis. In Harrison's Textbook of Internal Medicine, 15th ed. E. Braunwald et al. Eds. :517-530. McGraw-Hill. New York.
3. ARBISER, J.L., M.A. MOSES, C.A. FERNANDEZ, et al. 1997. Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc. Natl. Acad. Sci. USA 94: 861-866.
4. CHIN, L., A. TAM, J. POMERANTZ, et al. 1999. Essential role for oncogene Ras in tumour maintenance. Nature 400: 468-472.
5. STREIT, M., L. RICCARDI, P. VELASCO, et al. 1999. Thrombospondin-2: a potent endogenous inhibitor of tumour growth and angiogenesis. Proc. Natl. Acad. Sci. USA 96: 14888-14893.
6. LYDEN, D., A.Z. YOUNG, D. ZAGZAG, et al. 1999. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401: 670-677.
7. LYDEN, D., K. HATTORI & S. DIAS. 2001. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nature Med. 7: 1194-1201.
8. GIMBRONE, M.A., JR., R.S. COTRAN & J. FOLKMAN. 1973. Endothelial regeneration: studies with human endothelial cells in culture. Ser. Haemat. VI: 453-455.
9. JAFFE, E.A., R.L. NACHMAN, C.G. BECKER & R.C. MINICK. 1972. Culture of human endothelial cells derived from human cord umbilical cord veins. Circulation. 46: II-252.
10. O'REILLY, M.S., L. HOLMGREN, Y. SHING, et al. 1994. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 79: 315-328.
11. HOLMGREN, L., M.S. O'REILLY & J. FOLKMAN. 1995. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med. 1: 149-153.
12. GIMBRONE, M.A., JR, R.S. COTRAN, S.B. LEAPMAN & J. FOLKMAN. 1974. Tumor growth and neovascularization: an experimental model using rabbit cornea. J. Natl. Cancer Inst. 52: 413-427.
13. LANGER, R. & J. FOLKMAN. 1976. Polymers for sustained release of proteins and other macromolecules. Nature 263: 797-800.
14. SHING, Y., J. FOLKMAN, R. SULLIVAN, et al. 1984. Heparin-affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science 223: 1296-1299.
15. MUTHUKKARUPPAN, V.R. & R. AUERBACH. 1979. Angiogenesis in the mouse cornea. Science 205: 1416-1418.
16. FOLKMAN, J. 1985. Angiogenesis and its inhibitors. In Important Advances in Oncology. V.T. DeVita, Jr., S. Hellman & S.A. Rosenberg, Eds. :42-62. J.B. Lippincott. Philadelphia, PA.
17. KENYON, B.M., E.E. VOEST, C.C. CHEN, et al. 1996. A model of angiogenesis in the mouse cornea. Invest. Ophthal. Vis. Sci. 37: 1625-1632.
18. KAIPAINEN, A., J. KORHONEN, T. MUSTONEN, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl. Acad Sci USA 92: 3566-3570.
19. SKOBE, M., T. HAWIGHORST, D.G. JACKSON, et al. 2001. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nature Med. 7: 192-198.